New perspectives in advanced genitourinary malignancies.
نویسندگان
چکیده
The management of advanced genitourinary malignancies has undergone a major transformation with the advent of novel drugs and targeted therapies in recent years. Assessment of the treatment risks and benefits is required for each patient and therefore better knowledge of the different clinical and molecular aspects of these diseases is warranted. The results of further studies and biomarker validations are expected to provide more treatment options and improve outcomes in the future management of genitourinary malignancies.
منابع مشابه
Novel therapies in genitourinary cancer: an update
In recent years, new treatment for renal cell carcinoma (RCC) has been a spotlight in the field of cancer therapeutics. With several emerging agents branded as 'targeted therapy' now available, both medical oncologists and urologists are progressively more hopeful for better outcomes. The new remedies may provide patients with improved survival and at the same time less toxicity when compared t...
متن کاملUrological implications of concurrent bladder and lung cancer.
BACKGROUND Multiple primary malignancies are increasingly being detected among cancer patients. OBJECTIVES To investigate the co-occurrence of primary bladder cancer and primary lung cancer, two established smoking-related neoplasms characteristically associated with increased risk of secondary cancers. METHODS A retrospective search of the patient registry in our institution identified 25 ...
متن کاملTreatment Strategies in Advanced Prostate Cancer/Genitourinary Malignancies: The Use of Bisphosphonates Across the Continuum
University College Dublin, Mater Misericordiae Hospital, Dublin, Ireland Department of Urology and Transplantation, Edouard Herriot Hospital, Lyon, France Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy Department of Urology, Sant’Andrea Hospital, Rome, Italy ava i lable at www.sciencedirect .co...
متن کاملNanoparticle Albumin-Bound-Paclitaxel in the Treatment of Metastatic Urethral Adenocarcinoma: The Significance of Molecular Profiling and Targeted Therapy
Primary urethral cancer is rare and accounts for only 0.003% of all malignancies arising from the female genitourinary tract. Due to the rarity of this disease, no consensus exists regarding the optimal therapeutic approach. Nanoparticle albumin-bound-paclitaxel has been shown to be effective in the treatment of a number of malignancies including metastatic breast, pancreatic, and bladder cance...
متن کاملGenitourinary Oncology: Current Status and Future Challenges
IntroductIon Genitourinary oncology (GU Oncology) focuses on research and treatment of urinary system cancers in both genders, as well as malignancies affecting the male sexual organs. Sites included are the kidneys, bladder, prostate, and testes. These malignancies represent approximately one fourth of all solid tumors, however, the field remains underrepresented in the basic science, epidemio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Tumori
دوره 98 2 شماره
صفحات -
تاریخ انتشار 2012